Association of Glioblastoma Multiforme Stem Cell Characteristics, Differentiation, and Microglia Marker Genes with Patient Survival

The Impact of the Tumor Microenvironment on the Properties of Glioma Stem-Like Cells

(2017) Alessandra Audia et al.   Frontiers in Oncology

Prognostic impact of stem cell marker CD133 in 61 glioblastoma patients treated with concomitant chemoradiation: A prospective study.

(2017) P. Metellus et al.   JOURNAL OF CLINICAL ONCOLOGY

Asymmetric Distribution of GFAP in Glioma Multipotent Cells

(2016) Pierre-Olivier Guichet et al.   PLoS One

ABCG2 regulates self-renewal and stem cell marker expression but not tumorigenicity or radiation resistance of glioma cells

(2016) Boyoung Wee et al.   Scientific Reports

The role of CD95 and CD95 ligand in cancer

(2015) M E Peter et al.   CELL DEATH AND DIFFERENTIATION

Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis

(2015) Bin Wu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Osteopontin-CD44 Signaling in the Glioma Perivascular Niche Enhances Cancer Stem Cell Phenotypes and Promotes Aggressive Tumor Growth

(2014) Alexander Pietras et al.   Cell Stem Cell

A Phase II, Randomized, Study of Weekly APG101+Reirradiation versus Reirradiation in Progressive Glioblastoma

(2014) W. Wick et al.   CLINICAL CANCER RESEARCH

Glioma stem cells: turpis omen in nomen? (the evil in the name?)

(2014) E. Binda et al.   JOURNAL OF INTERNAL MEDICINE

Nanog1 in NTERA-2 and Recombinant NanogP8 from Somatic Cancer Cells Adopt Multiple Protein Conformations and Migrate at Multiple M.W Species

(2014) Bigang Liu et al.   PLoS One

Sialidase NEU4 is involved in glioblastoma stem cell survival

(2014) I Silvestri et al.   Cell Death & Disease

In vitro Analysis of Neurospheres Derived from Glioblastoma Primary Culture: A Novel Methodology Paradigm

(2014) Lorena Favaro Pavon et al.   Frontiers in Neurology

CD133 Is Essential for Glioblastoma Stem Cell Maintenance

(2013) Paola Brescia et al.   STEM CELLS

Study of chemoresistant CD133+ cancer stem cells from human glioblastoma cell line U138MG using multiple assays

(2012) Sudha Warrier et al.   CELL BIOLOGY INTERNATIONAL

MEF Promotes Stemness in the Pathogenesis of Gliomas

(2012) Elena Bazzoli et al.   Cell Stem Cell

Glioblastoma Multiforme

(2012) Kevin Anton et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Unknown

(2012) Salvatore Coniglio et al.   MOLECULAR MEDICINE

CD133 as a Marker for Regulation and Potential for Targeted Therapies in Glioblastoma Multiforme

(2012) Winward Choy et al.   NEUROSURGERY CLINICS OF NORTH AMERICA

Current Strategies for Identification of Glioma Stem Cells: Adequate or Unsatisfactory?

(2012) Paola Brescia et al.   Journal of Oncology

Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas

(2011) Yuji Guo et al.   HISTOPATHOLOGY

The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas

(2011) Kyung-Jung Kim et al.   NEUROPATHOLOGY

Nanog, Gli, and p53: a new network of stemness in development and cancer

(2010) Sebastian Brandner   EMBO JOURNAL

NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53

(2010) Marie Zbinden et al.   EMBO JOURNAL

PTEN augments SPARC suppression of proliferation and inhibits SPARC-induced migration by suppressing SHC-RAF-ERK and AKT signaling

(2010) Stacey L. Thomas et al.   NEURO-ONCOLOGY

Secreted protein, acidic and rich in cysteine (SPARC) expression in astrocytic tumour cells negatively correlates with proliferation, while vascular SPARC expression is associated with patient survival

(2010) D. Capper et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Nestin Is Required for the Proper Self-Renewal of Neural Stem Cells

(2010) Donghyun Park et al.   STEM CELLS

PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like Cells

(2009) Anne-Marie Bleau et al.   Cell Stem Cell

Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors

(2009) Qinghai Liu et al.   JOURNAL OF NEURO-ONCOLOGY

Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients

(2008) F. Zeppernick et al.   CLINICAL CANCER RESEARCH

Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells

(2008) Lilly Y. W. Bourguignon et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients

(2008) Mingyu Zhang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IDENTIFICATION OF A2B5+CD133− TUMOR-INITIATING CELLS IN ADULT HUMAN GLIOMAS

(2008) Alfred T. Ogden et al.   NEUROSURGERY

CD133 Is a Marker of Bioenergetic Stress in Human Glioma

(2008) Corinne E. Griguer et al.   PLoS One

CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells

(2007) Jian Wang et al.   INTERNATIONAL JOURNAL OF CANCER